Allele frequencies in the group of 110 patients and in a healthy white population
. | Patients . | . | . | White population* . | . | . | ||||
---|---|---|---|---|---|---|---|---|---|---|
Genes . | A, % . | B, % . | C, % . | A, % . | B, % . | C, % . | ||||
MDR1 (1) | 73 | 26 | 1 | 74 | 24.04 | 1.96 | ||||
MDR1 (2) | 31 | 50 | 19 | 41.4 | 45.9 | 12.6 | ||||
TOP2A | 62 | 32 | 6 | 52.5 | 39.9 | 7.5 | ||||
SXR (1) | 43 | 44 | 13 | 36 | 48 | 16 | ||||
SXR (2) | 42 | 44 | 14 | 47.8 | 42.7 | 9.5 | ||||
GSTT1 | 87 | 7 | 6 | 53.6 | 39.2 | 7.2 | ||||
SULT1C2 | 50 | 39 | 11 | 65.3 | 31 | 3.7 | ||||
VEGF (1) | 19 | 61 | 20 | 38.8 | 47 | 14.2 | ||||
VEGF (2) | 46 | 40 | 14 | 49 | 42 | 9 | ||||
XPD | 44 | 46 | 10 | 34.8 | 48.4 | 16.8 | ||||
XPA | 48.3 | 40.5 | 11.1 | 38.8 | 47 | 14.2 | ||||
ERCC1 | 72 | 25 | 3 | 59.4 | 35.4 | 5.2 | ||||
ERCC5 | 32 | 45 | 23 | 29.2 | 49.7 | 21.2 | ||||
CDA | 49.5 | 39.4 | 11.1 | — | — | — |
. | Patients . | . | . | White population* . | . | . | ||||
---|---|---|---|---|---|---|---|---|---|---|
Genes . | A, % . | B, % . | C, % . | A, % . | B, % . | C, % . | ||||
MDR1 (1) | 73 | 26 | 1 | 74 | 24.04 | 1.96 | ||||
MDR1 (2) | 31 | 50 | 19 | 41.4 | 45.9 | 12.6 | ||||
TOP2A | 62 | 32 | 6 | 52.5 | 39.9 | 7.5 | ||||
SXR (1) | 43 | 44 | 13 | 36 | 48 | 16 | ||||
SXR (2) | 42 | 44 | 14 | 47.8 | 42.7 | 9.5 | ||||
GSTT1 | 87 | 7 | 6 | 53.6 | 39.2 | 7.2 | ||||
SULT1C2 | 50 | 39 | 11 | 65.3 | 31 | 3.7 | ||||
VEGF (1) | 19 | 61 | 20 | 38.8 | 47 | 14.2 | ||||
VEGF (2) | 46 | 40 | 14 | 49 | 42 | 9 | ||||
XPD | 44 | 46 | 10 | 34.8 | 48.4 | 16.8 | ||||
XPA | 48.3 | 40.5 | 11.1 | 38.8 | 47 | 14.2 | ||||
ERCC1 | 72 | 25 | 3 | 59.4 | 35.4 | 5.2 | ||||
ERCC5 | 32 | 45 | 23 | 29.2 | 49.7 | 21.2 | ||||
CDA | 49.5 | 39.4 | 11.1 | — | — | — |
A indicates homozygous wild type; B, heterozygous; C, homozygous for SNP; and —, not available.
NCBI/Celera.